ArriVent BioPharma, Inc. (AVBP) Misses Q3 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts AVBP Hot Sheet
Join SI Premium – FREE
ArriVent BioPharma, Inc. (NASDAQ: AVBP) reported Q3 EPS of ($0.61), $0.07 worse than the analyst estimate of ($0.54).
For earnings history and earnings-related data on ArriVent BioPharma, Inc. (AVBP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Veralto Corporation (VLTO) Tops Q3 EPS by 23c; raises guidance
- Ingram Micro Holding Corporation (INGM) Tops Q3 EPS by 6c ; Offers Guidance
- Miami International Holdings, Inc. (MIAX) Tops Q3 EPS by 17c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
